Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma

Olson; Zeynep Eroglu; Bruce Brockstein; Andrew S Poklepovic; Madhuri Bajaj; Sunil Babu; Sigrun Hallmeyer; Mario Velasco; Jose Lutzky; Emily Higgs; Riyue Bao; Timothy C Carll; Brian Labadie; Thomas Krausz; Yuanyuan Zha; Theodore Karrison; Vernon K Sondak; Thomas F Gajewski; Nikhil I Khushalani; Jason J Luke; Advocate Hematology/Oncology Faculty - Lutheran General; Advocate Internal Medicine Faculty - Lutheran General

doi:10.1200/JCO.21.00079

Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma

Olson
, Zeynep Eroglu
, Bruce Brockstein
, Andrew S Poklepovic
, Madhuri Bajaj
, Sunil Babu
, Sigrun Hallmeyer
, Mario Velasco
, Jose Lutzky
, Emily Higgs
, Riyue Bao
, Timothy C Carll
, Brian Labadie
, Thomas Krausz
, Yuanyuan Zha
, Theodore Karrison
, Vernon K Sondak
, Thomas F Gajewski
, Nikhil I Khushalani
, Jason J Luke

Advocate Hematology/Oncology Faculty - Lutheran General, Advocate Internal Medicine Faculty - Lutheran General

Advocate Aurora Health

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DOIs	https://doi.org/10.1200/JCO.21.00079
Status	Published - Aug 20 2021

Access to Document

10.1200/JCO.21.00079License: Unspecified

https://libkey.io/libraries/1712/33945288

Cite this

Olson, Eroglu, Z., Brockstein, B., Poklepovic, A. S., Bajaj, M., Babu, S., Hallmeyer, S., Velasco, M., Lutzky, J., Higgs, E., Bao, R., Carll, T. C., Labadie, B., Krausz, T., Zha, Y., Karrison, T., Sondak, V. K., Gajewski, T. F., Khushalani, N. I., ... Advocate Internal Medicine Faculty - Lutheran General (2021). Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/JCO.21.00079

Olson, Eroglu, Z, Brockstein, B, Poklepovic, AS, Bajaj, M, Babu, S, Hallmeyer, S, Velasco, M, Lutzky, J, Higgs, E, Bao, R, Carll, TC, Labadie, B, Krausz, T, Zha, Y, Karrison, T, Sondak, VK, Gajewski, TF, Khushalani, NI, Luke, JJ, Advocate Hematology/Oncology Faculty - Lutheran General & Advocate Internal Medicine Faculty - Lutheran General 2021, 'Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma', Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/JCO.21.00079

@article{365a99fdc0944141abcd136a3587b039,

title = "Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma",

author = "Olson and Zeynep Eroglu and Bruce Brockstein and Poklepovic, \{Andrew S\} and Madhuri Bajaj and Sunil Babu and Sigrun Hallmeyer and Mario Velasco and Jose Lutzky and Emily Higgs and Riyue Bao and Carll, \{Timothy C\} and Brian Labadie and Thomas Krausz and Yuanyuan Zha and Theodore Karrison and Sondak, \{Vernon K\} and Gajewski, \{Thomas F\} and Khushalani, \{Nikhil I\} and Luke, \{Jason J\} and \{Advocate Hematology/Oncology Faculty - Lutheran General\} and \{Advocate Internal Medicine Faculty - Lutheran General\}",

note = "Olson DJ, Eroglu Z, Brockstein B, et al. Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. J Clin Oncol. 2021;39(24):2647-2655. doi:10.1200/JCO.21.00079",

year = "2021",

month = aug,

day = "20",

doi = "10.1200/JCO.21.00079",

language = "American English",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

}

TY - JOUR

T1 - Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma

AU - Olson, null

AU - Eroglu, Zeynep

AU - Brockstein, Bruce

AU - Poklepovic, Andrew S

AU - Bajaj, Madhuri

AU - Babu, Sunil

AU - Hallmeyer, Sigrun

AU - Velasco, Mario

AU - Lutzky, Jose

AU - Higgs, Emily

AU - Bao, Riyue

AU - Carll, Timothy C

AU - Labadie, Brian

AU - Krausz, Thomas

AU - Zha, Yuanyuan

AU - Karrison, Theodore

AU - Sondak, Vernon K

AU - Gajewski, Thomas F

AU - Khushalani, Nikhil I

AU - Luke, Jason J

AU - Advocate Hematology/Oncology Faculty - Lutheran General, null

AU - Advocate Internal Medicine Faculty - Lutheran General, null

N1 - Olson DJ, Eroglu Z, Brockstein B, et al. Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. J Clin Oncol. 2021;39(24):2647-2655. doi:10.1200/JCO.21.00079

PY - 2021/8/20

Y1 - 2021/8/20

UR - https://institutionalrepository.aah.org/alghhemoncfaculty/2

UR - https://libkey.io/libraries/1712/33945288

U2 - 10.1200/JCO.21.00079

DO - 10.1200/JCO.21.00079

M3 - Article

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ER -

Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma

Access to Document

Other files and links

Cite this